Bristol-Myers Squibb Rights
CELG.RT
24 hedge funds and large institutions have $57.9K invested in Bristol-Myers Squibb Rights in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 20 → 24 (+4)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
14% less capital invested
Capital invested by funds: $67K → $57.9K (-$9.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.13K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9 |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$112 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$47 |
CELG.RT Hedge Fund Activity: Q2 2025 in Review
24 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q2 2025, worth a combined $57.9K — down 14% from $67K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELG.RT positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.13K. The largest seller was Two Sigma Securities, cutting an estimated $112.
- 24 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q2 2025, up from 20 in Q1 2025.
- Funds reported $57.9K of Bristol-Myers Squibb Rights stock for Q2 2025, down 14% quarter-over-quarter.
- 4 funds opened new Bristol-Myers Squibb Rights positions in Q2 2025 and 0 closed out, a net change of +4 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q2 2025 was Susquehanna International Group, an estimated $1.13K added.
- The largest Bristol-Myers Squibb Rights seller in Q2 2025 was Two Sigma Securities, an estimated $112 sold.
Based on aggregated 13F filings for Q2 2025.